Bracco Imaging is focusing its efforts in some specific R&D areas:
Cardiovascular disease: identification of patients at risk due to the presence of unstable plaque and ability to monitor response to treatment;
Oncology: targeted agents to visualize and characterize angiogenesis in order to identify and monitor patients responding to novel anti-angiogenic therapies;
Degenerative diseases: agents able to visualize and characterize disease progression to enable the doctor to monitor response to treatment.
Our main R&D Targets
We aim to provide Integrated Imaging Solutions to the Healthcare Community for Global Patient Management.
Our main R&D targets are:
To improve Patient Management in the above areas through Functional Imaging and/or Molecular Imaging with the goal of supporting the doctor in his selection and modulation of targeted therapies guiding him in his interventions with minimally invasive techniques;
To develop New Business Patient Management Solutions with novel Information Technology tools for mining & handling Imaging & Patient Data so as to provide: